| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 124.873 | 168.590 | 174.190 | 192.854 | 232.213 | 351.236 | 260.028 | 257.989 | 304.857 | 407.955 |
| Total Income - EUR | 124.886 | 173.120 | 174.336 | 192.940 | 232.276 | 352.106 | 262.351 | 261.337 | 306.109 | 410.668 |
| Total Expenses - EUR | 107.872 | 154.089 | 170.884 | 189.627 | 185.494 | 263.072 | 246.170 | 261.954 | 276.621 | 383.350 |
| Gross Profit/Loss - EUR | 17.014 | 19.031 | 3.452 | 3.312 | 46.782 | 89.033 | 16.182 | -617 | 29.489 | 27.318 |
| Net Profit/Loss - EUR | 12.602 | 14.845 | 932 | 1.375 | 44.459 | 85.910 | 13.873 | -2.930 | 26.580 | 15.244 |
| Employees | 12 | 14 | 14 | 16 | 13 | 11 | 9 | 8 | 9 | 11 |
Check the financial reports for the company - Loxan Magnus Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.738 | 10.418 | 2.010 | 12.187 | 7.926 | 7.822 | 88.407 | 76.741 | 67.639 | 58.496 |
| Current Assets | 48.757 | 46.300 | 71.065 | 57.439 | 93.652 | 188.291 | 141.575 | 121.444 | 146.645 | 58.746 |
| Inventories | 0 | 0 | 0 | 613 | 0 | 0 | 556 | 558 | 150 | 182 |
| Receivables | 27.472 | 34.798 | 39.452 | 42.294 | 34.651 | 34.754 | 54.330 | 40.913 | 44.895 | 46.782 |
| Cash | 21.285 | 11.501 | 31.613 | 14.532 | 59.001 | 153.537 | 86.689 | 79.974 | 101.599 | 11.783 |
| Shareholders Funds | 40.384 | 26.222 | 23.791 | 24.730 | 68.710 | 138.052 | 145.885 | 143.408 | 169.554 | 67.414 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.445 | 31.096 | 49.420 | 45.339 | 34.133 | 58.601 | 85.044 | 55.786 | 46.032 | 51.038 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Loxan Magnus Medical Srl